Document is current
Any future updates will be listed below
-
Authors
DeAngelo, Daniel J. http://orcid.org/0000-0001-7865-2306
Advani, Anjali S. http://orcid.org/0000-0003-0015-5902
Marks, David I.
Stelljes, Matthias
Liedtke, Michaela
Stock, Wendy
Gökbuget, Nicola
Jabbour, Elias
Merchant, Akil
Wang, Tao
Vandendries, Erik
Neuhof, Alexander
Kantarjian, Hagop
O’Brien, Susan
- License Information
-
More Information
Article History
Received: 19 March 2020
Revised: 16 June 2020
Accepted: 6 July 2020
First Online: 7 August 2020
Conflict of interest
: D.J.D. declares honoraria from Pfizer. A.S.A. declares consulting fees and honoraria from Pfizer, research funding from Amgen and AbbVie, and honoraria from Kite Pharma. D.I.M. declares consultancy with Pfizer, Amgen, and Novartis. M.S. declares research support and honoraria from Pfizer. M.L. declares honoraria from Pfizer. W.S. declares honoraria from Jazz Pharmaceuticals. N.G. declares research support and honoraria from Amgen and Pfizer. E.J. has received research grants and consultancy fees from Amgen, Pfizer, Takeda, Adaptive Biotechnologies, AbbVie, and Bristol-Myers Squibb. A.M. has received research support from Pfizer. T.W., E.V., and A.N. are employees of and own stock in Pfizer. H.K. declares honoraria from AbbVie, Amgen, ARIAD, Bristol-Myers Squibb, ImmunoGen, and Pfizer. S.O. declares research support and honoraria from Pfizer.
